Waters Corporation

NYSE WAT

Data sourced from

and

Daily

Download Data

Waters Corporation Price to Sales Ratio (P/S) on June 03, 2024: 6.32

Waters Corporation Price to Sales Ratio (P/S) is 6.32 on June 03, 2024, a 22.38% change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.

Waters Corporation 52-week high Price to Sales Ratio (P/S) is 7.38 on May 15, 2024, which is 16.74% above the current Price to Sales Ratio (P/S).
Waters Corporation 52-week low Price to Sales Ratio (P/S) is 4.65 on October 30, 2023, which is -26.41% below the current Price to Sales Ratio (P/S).
Waters Corporation average Price to Sales Ratio (P/S) for the last 52 weeks is 5.90.

NYSE: WAT

Waters Corporation

CEO	Dr. Udit Batra Ph.D.
IPO Date	Nov. 16, 1995
Location	United States
Headquarters	34 Maple Street, Milford, MA, United States, 01757
Employees	7,900
Sector	Healthcare
Industry	Diagnostics & research

Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Key trends